CN103664848B - 一种霉酚酸的提取方法 - Google Patents
一种霉酚酸的提取方法 Download PDFInfo
- Publication number
- CN103664848B CN103664848B CN201210339759.3A CN201210339759A CN103664848B CN 103664848 B CN103664848 B CN 103664848B CN 201210339759 A CN201210339759 A CN 201210339759A CN 103664848 B CN103664848 B CN 103664848B
- Authority
- CN
- China
- Prior art keywords
- mycophenolic acid
- filtrate
- organic solvent
- volume
- filter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 title claims abstract description 86
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 title claims abstract description 85
- 229960000951 mycophenolic acid Drugs 0.000 title claims abstract description 84
- 238000000034 method Methods 0.000 title claims abstract description 49
- 239000000706 filtrate Substances 0.000 claims abstract description 58
- 238000000855 fermentation Methods 0.000 claims abstract description 40
- 230000004151 fermentation Effects 0.000 claims abstract description 40
- 239000003960 organic solvent Substances 0.000 claims abstract description 40
- 238000001914 filtration Methods 0.000 claims abstract description 21
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 12
- 239000001110 calcium chloride Substances 0.000 claims abstract description 12
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 238000000605 extraction Methods 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 24
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 11
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical group CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 11
- 239000012043 crude product Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000004042 decolorization Methods 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 3
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 3
- 229940090181 propyl acetate Drugs 0.000 claims description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 239000013078 crystal Substances 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 239000007788 liquid Substances 0.000 description 26
- 238000003756 stirring Methods 0.000 description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000000463 material Substances 0.000 description 20
- 239000012065 filter cake Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 235000021395 porridge Nutrition 0.000 description 12
- 239000010451 perlite Substances 0.000 description 11
- 235000019362 perlite Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 239000010409 thin film Substances 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000004062 sedimentation Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000011085 pressure filtration Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- RTGDFNSFWBGLEC-SYZQJQIISA-N mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-SYZQJQIISA-N 0.000 description 2
- 229960004866 mycophenolate mofetil Drugs 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000003495 polar organic solvent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 101710200424 Inosine-5'-monophosphate dehydrogenase Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210339759.3A CN103664848B (zh) | 2012-09-13 | 2012-09-13 | 一种霉酚酸的提取方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210339759.3A CN103664848B (zh) | 2012-09-13 | 2012-09-13 | 一种霉酚酸的提取方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103664848A CN103664848A (zh) | 2014-03-26 |
CN103664848B true CN103664848B (zh) | 2016-03-23 |
Family
ID=50303723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210339759.3A Active CN103664848B (zh) | 2012-09-13 | 2012-09-13 | 一种霉酚酸的提取方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103664848B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103880798B (zh) * | 2012-12-19 | 2016-04-20 | 北大方正集团有限公司 | 一种纯化霉酚酸的方法 |
CN115889420A (zh) * | 2022-12-23 | 2023-04-04 | 青岛农业大学 | 一种碱性霉酚酸菌渣中去除霉酚酸的方法 |
CN116041293A (zh) * | 2023-02-08 | 2023-05-02 | 丽珠集团新北江制药股份有限公司 | 一种霉酚酸纯化的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1687069A (zh) * | 2005-04-27 | 2005-10-26 | 浙江钱江生物化学股份有限公司 | 维生素b2提取方法 |
WO2006050050A2 (en) * | 2004-10-29 | 2006-05-11 | Centocor, Inc. | Chemically defined media compositions |
CN101643400A (zh) * | 2009-06-26 | 2010-02-10 | 安徽丰原发酵技术工程研究有限公司 | 一种从发酵液中提取丁二酸的方法 |
CN102399205A (zh) * | 2011-12-13 | 2012-04-04 | 福建和泉生物科技有限公司 | 一种霉酚酸纯化工艺 |
CN102532078A (zh) * | 2012-01-10 | 2012-07-04 | 福建和泉生物科技有限公司 | 一种从霉酚酸发酵液直接生产制备霉酚酸钠的方法 |
-
2012
- 2012-09-13 CN CN201210339759.3A patent/CN103664848B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006050050A2 (en) * | 2004-10-29 | 2006-05-11 | Centocor, Inc. | Chemically defined media compositions |
CN1687069A (zh) * | 2005-04-27 | 2005-10-26 | 浙江钱江生物化学股份有限公司 | 维生素b2提取方法 |
CN101643400A (zh) * | 2009-06-26 | 2010-02-10 | 安徽丰原发酵技术工程研究有限公司 | 一种从发酵液中提取丁二酸的方法 |
CN102399205A (zh) * | 2011-12-13 | 2012-04-04 | 福建和泉生物科技有限公司 | 一种霉酚酸纯化工艺 |
CN102532078A (zh) * | 2012-01-10 | 2012-07-04 | 福建和泉生物科技有限公司 | 一种从霉酚酸发酵液直接生产制备霉酚酸钠的方法 |
Non-Patent Citations (3)
Title |
---|
Enhancing the sporulation of Streptomyces kasugaensis by culture optimization;Won-Bok Chae,等;《Korean J. Chem. Eng.》;20090228;第26卷(第2期);438-443 * |
膜分离技术应用于霉酚酸生产的工艺研究;张斌 等;《食品与发酵工业》;20110731;第37卷(第7期);98-102 * |
霉酚酸提取工艺的设计与改进;张斌;《浙江工业大学硕士学位论文》;20120615;17、28、41-42 * |
Also Published As
Publication number | Publication date |
---|---|
CN103664848A (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102659882B (zh) | 一种酒石酸乙酰异戊酰泰乐菌素的提取方法 | |
CN103819326B (zh) | 一种从微生物中分离纯化辅酶q10的方法 | |
CN103030676A (zh) | 利用结晶法分步提取阿维菌素b1组分和b2组分的工艺 | |
CN102465164A (zh) | 普那霉素的制备方法 | |
CN103664848B (zh) | 一种霉酚酸的提取方法 | |
CN101914098B (zh) | 美罗培南三水合物结晶的制备方法 | |
CN101143887B (zh) | 从枇杷叶中分离制备科罗索酸的方法 | |
CN104557967A (zh) | 一种高纯度米尔贝霉素的生产方法 | |
CN103360411B (zh) | 依维莫司结晶提纯方法 | |
CN103159816A (zh) | 一种从植物甾醇发酵液中提取4-雄烯二酮的方法 | |
WO2020207130A1 (zh) | 一种青蒿素分离纯化工艺 | |
CN111635402B (zh) | 吡咯喹啉醌的分离纯化方法 | |
CN110105195A (zh) | 一种从青蒿蜡油中提取二氢青蒿酸的方法 | |
CN103570655B (zh) | 一种提取霉酚酸的方法 | |
CN103724288A (zh) | 原甲酸三乙酯法制备1h-四氮唑乙酸的后处理方法 | |
CN107304186B (zh) | 一种奥拉帕尼的精制方法 | |
CN108976270B (zh) | 一种高纯度多拉菌素的制备方法 | |
CN109851568B (zh) | 一种丙硫菌唑的提纯方法 | |
US9815761B2 (en) | Method for extracting ferulic acid and/or its salts | |
CN107033114B (zh) | 一种二氢杨梅素的分离纯化方法 | |
WO2020074008A1 (zh) | 一种烟曲霉素的提取纯化方法 | |
CN106883227B (zh) | 通过麦角菌发酵废料制备麦角新碱的方法 | |
CN103880798B (zh) | 一种纯化霉酚酸的方法 | |
CN109796333B (zh) | 一种从发酵液中提取纯化普伐他汀钠的方法 | |
CN102952165A (zh) | 一种从木糖母液中提取l-阿拉伯糖的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100871, Beijing, Haidian District, Cheng Fu Road, No. 298, Zhongguancun Fangzheng building, 5 floor Patentee after: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee after: CHONGQING DAXIN PHARMACEUTICAL Co.,Ltd. Patentee after: PKU HEALTHCARE INDUSTRY Group Address before: 100871, Beijing, Haidian District, Cheng Fu Road, No. 298, Zhongguancun Fangzheng building, 5 floor Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee before: Peking University International Hospital Group Chongqing Daxin Pharmaceutical Co.,Ltd. Patentee before: Pku Healthcare Industry Group Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221018 Address after: 3007, Hengqin international financial center building, No. 58, Huajin street, Hengqin new area, Zhuhai, Guangdong 519031 Patentee after: New founder holdings development Co.,Ltd. Patentee after: CHONGQING DAXIN PHARMACEUTICAL Co.,Ltd. Patentee after: Peking University Medical Management Co.,Ltd. Address before: 100871, Beijing, Haidian District, Cheng Fu Road, No. 298, Zhongguancun Fangzheng building, 5 floor Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee before: CHONGQING DAXIN PHARMACEUTICAL Co.,Ltd. Patentee before: PKU HEALTHCARE INDUSTRY Group |